Nucleus accumbens neuronal activity in freely behaving rats is modulated following acute and chronic methylphenidate administration

Brain Research Bulletin

Volumn 87, Issue 4-5, 2012, Pages 445-456

  Chong, Samuel L ^a   Claussen, Catherine M ^a   Dafny, Nachum ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Behavior sensitization tolerance; Electrophysiology; Methylphenidate; Nucleus accumbens

Indexed keywords

METHYLPHENIDATE;

ACUTE DRUG ADMINISTRATION; ADAPTATION; AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN NERVE CELL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; HOMEOSTASIS; MALE; MICROELECTRODE; MOLECULAR MECHANICS; NERVE CONDUCTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; MALE; METHYLPHENIDATE; MICROELECTRODES; MOTOR ACTIVITY; NEURONS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84857921641     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.01.004     Document Type: Article

References (111)

1. Accardo P., Blondis T.A. What's all the fuss about Ritalin?. J. Pediatr. 2001, 138:6-9.
2. Arnsten A.F., Dudley A.G. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav. Brain Funct. 2005, 1:2.
3. Arnsten A.F., Vijayraghavan S. Staying in touch with methylphenidate: AHDH and sensory processing, focus on "methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats" J. Neurophysiol. 2006, 96:524-525.
4. Bell K., Kalivas P.W. Context-specific cross-sensitization between systemic cocaine and intra-accumbens AMPA infusion in the rat. Psychopharmacology (Berl.) 1996, 127:377-383.
5. Berridge C.W., Arnsten A.F., Foote S.L. Noradrenergic modulation of cognitive function: clinical implications of anatomical, electrophysiological and behavioural studies in animal models. Psychol. Med. 1993, 23:557-564.
6. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., Hamilton C., Spencer R.C. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol. Psychiatry 2006, 60:1111-1120.
7. Bidwell L.C., McClernon F.J., Kollins S.H. Cognitive enhancers for the treatment of ADHD. Pharmacol. Biochem. Behav. 2011, 99:262-274.
8. Burrone J., Murthy V.N. Synaptic gain control and homeostasis. Curr. Opin. Neurobiol. 2003, 13:560-567.
9. Carelli R.M., Ijames S.G. Selective activation of accumbens neurons by cocaine-associated stimuli during a water/cocaine multiple schedule. Brain Res. 2001, 907:156-161.
10. Chao J., Nestler E.J. Molecular neurobiology of drug addiction. Annu. Rev. Med. 2004, 55:113-132.
11. Claussen C.M., Dafny N. Acute and chronic methylphenidate modulates the neuronal activity of the caudate nucleus recorded from freely behaving rats. Brain Res. Bull. 2011.
12. Dafny N. Neurophysiological evidence for tolerance and dependence on opiates: simultaneous multiunit recordings from septum, thalamus, and caudate nucleus. J. Neurosci. Res. 1980, 5:339-349.
13. Dafny N. The hypothalamus exhibits electrophysiologic evidence for morphine tolerance and dependence. Exp. Neurol. 1982, 77:66-77.
14. Dafny N. Interferon modifies EEG and EEG-like activity recorded from sensory, motor, and limbic system structures in freely behaving rats. Neurotoxicology 1983, 4:235-240.
15. Dafny N., Gilman S. Characterization of spontaneous unit activity in hypothalamus and reticular formation recorded with semi-microelectrodes. Brain Res. 1973, 59:243-255.
16. Dafny N., Terkel J. Hypothalamic neuronal activity associated with onset of pseudopregnancy in the rat. Neuroendocrinology 1990, 51:459-467.
17. Dafny N., Yang P.B. The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res. Bull. 2006, 68:393-405.
18. Dafny N., Brown M., Burks T.F., Rigor B.M. Unit activity recorded simultaneously from medial thalamus and caudate nucleus in naive and morphine-dependent rats. Exp. Neurol. 1979, 64:216-224.
19. Dafny N., Rigor B.M., Burks T.F. Dependence and tolerance: multiunit recording from central gray, mesencephalic reticular formation, and medial thalamus in freely behaving rats. Exp. Neurol. 1980, 68:217-227.
20. Dafny N., Burks T.F., Bergmann F. Dose effects of morphine on the spontaneous unit activity recorded from the thalamus, hypothalamus, septum, hippocampus, reticular formation, central gray, and caudate nucleus. J. Neurosci. Res. 1983, 9:115-126.
21. Deadwyler S.A., Hayashizaki S., Cheer J., Hampson R.E. Reward, memory and substance abuse: functional neuronal circuits in the nucleus accumbens. Neurosci. Biobehav. Rev. 2004, 27:703-711.
22. Devilbiss D.M., Berridge C.W. Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. J. Pharmacol. Exp. Ther. 2006, 319:1327-1335.
23. Einhorn L.C., Johansen P.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J. Neurosci. 1988, 8:100-112.
24. Everitt B.J., Wolf M.E. Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci. 2002, 22:3312-3320.
25. Gatley S.J., Volkow N.D., Gifford A.N., Fowler J.S., Dewey S.L., Ding Y.S., Logan J. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology (Berl.) 1999, 146:93-100.
26. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Dose response characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle. Brain Res. 1996, 727:13-21.
27. Gaytan O., Ghelani D., Martin S., Swann A., Dafny N. Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat. Brain Res. 1997, 777:1-12.
28. Gaytan O., al-Rahim S., Swann A., Dafny N. Sensitization to locomotor effects of methylphenidate in the rat. Life Sci. 1997, 61:PL101-PL107.
29. Gaytan O., Swann A., Dafny N. Diurnal differences in rat's motor response to amphetamine. Eur. J. Pharmacol. 1998, 345:119-128.
30. Gaytan O., Swann A., Dafny N. Time-dependent differences in the rat's motor response to amphetamine. Pharmacol. Biochem. Behav. 1998, 59:459-467.
31. Gaytan O., Yang P., Swann A., Dafny N. Diurnal differences in sensitization to methylphenidate. Brain Res. 2000, 864:24-39.
32. Gerasimov M.R., Franceschi M., Volkow N.D., Rice O., Schiffer W.K., Dewey S.L. Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor. Synapse 2000, 38:432-437.
33. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., Molina P.E., Dewey S.L. Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J. Pharmacol. Exp. Ther. 2000, 295:51-57.
34. Gessa G.L., Pani L., Serra G., Fratta W. Animal models of mania. Adv. Biochem. Psychopharmacol. 1995, 49:43-66.
35. Ghitza U.E., Fabbricatore A.T., Prokopenko V.F., West M.O. Differences between accumbens core and shell neurons exhibiting phasic firing patterns related to drug-seeking behavior during a discriminative-stimulus task. J. Neurophysiol. 2004, 92:1608-1614.
36. Girault J.A., Greengard P. The neurobiology of dopamine signaling. Arch. Neurol. 2004, 61:641-644.
37. Greely H., Sahakian B., Harris J., Kessler R.C., Gazzaniga M., Campbell P., Farah M.J. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008, 456:702-705.
38. Greenhill L., Kollins S., Abikoff H., McCracken J., Riddle M., Swanson J., McGough J., Wigal S., Wigal T., Vitiello B., Skrobala A., Posner K., Ghuman J., Cunningham C., Davies M., Chuang S., Cooper T. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J. Am. Acad. Child Adolesc. Psychiatry 2006, 45:1284-1293.
39. Harvey J., Lacey M.G. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation. J. Physiol. 1996, 492(Pt 1):143-154.
40. Huang Y.H., Schlüter O.M., Dong Y. Cocaine-induced homeostatic regulation and dysregulation of nucleus accumbens neurons. Behav. Brain Res. 2010, 216:9-18.
41. Kalivas P.W. Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend. 1995, 37:95-100.
42. Kalivas P.W. The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci. 2009, 10:561-572.
43. Kalivas P.W., Duffy P. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 1990, 5:48-58.
44. Kalivas P.W., Duffy P. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J. Neurosci. 1990, 10:2940-2949.
45. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev. 1991, 16:223-244.
46. Kalivas P.W., Lalumiere R.T., Knackstedt L., Shen H. Glutamate transmission in addiction. Neuropharmacology 2009, 56(Suppl. 1):169-173.
47. Kelley A.E., Domesick V.B., Nauta W.J. The amygdalostriatal projection in the rat - an anatomical study by anterograde and retrograde tracing methods. Neuroscience 1982, 7:615-630.
48. Kita H., Kitai S.T. Amygdaloid projections to the frontal cortex and the striatum in the rat. J. Comp. Neurol. 1990, 298:40-49.
49. Kolb B., Pellis S., Robinson T.E. Plasticity and functions of the orbital frontal cortex. Brain Cogn. 2004, 55:104-115.
50. Kollins S., Greenhill L., Swanson J., Wigal S., Abikoff H., McCracken J., Riddle M., McGough J., Vitiello B., Wigal T., Skrobala A., Posner K., Ghuman J., Davies M., Cunningham C., Bauzo A. Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). J. Am. Acad. Child Adolesc. Psychiatry 2006, 45:1275-1283.
51. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 1988, 242:715-723.
52. Kuczenski R., Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 1997, 68:2032-2037.
53. Kuczenski R., Segal D.S. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J. Neurosci. 2002, 22:7264-7271.
54. Kuczenski R., Segal D.S., Cho A.K., Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 1995, 15:1308-1317.
55. Kuczenski R., Segal D.S., Todd P.K. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology (Berl.) 1997, 134:221-229.
56. Lee M.J., Swann A.C., Dafny N. Methylphenidate sensitization is prevented by prefrontal cortex lesion. Brain Res. Bull. 2008, 76:131-140.
57. Levin F.R., Kleber H.D. Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harv. Rev. Psychiatry 1995, 2:246-258.
58. Liberman R.P. Schizophrenia practice guideline. Am. J. Psychiatry 1997, 154:1792-1793. author reply 1793-1794.
59. McDonald A.J. Topographical organization of amygdaloid projections to the caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain. Neuroscience 1991, 44:15-33.
60. Miserendino M.J., Nestler E.J. Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res. 1995, 674:299-306.
61. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 2004, 47(Suppl 1):24-32.
62. Nicola S.M., Kombian S.B., Malenka R.C. Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors. J. Neurosci. 1996, 16:1591-1604.
63. Paximos G., Watson C. The Rat Brain in Sterotaxic Coordinates 1986, Academic Press, Orlando. 2nd ed.
64. Pessiglione M., Seymour B., Flandin G., Dolan R.J., Frith C.D. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006, 442:1042-1045.
65. Phillipson O.T., Griffiths A.C. The topographic order of inputs to nucleus accumbens in the rat. Neuroscience 1985, 16:275-296.
66. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
67. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Brain Res. Rev. 1997, 25:192-216.
68. Pierce R.C., Duffy P., Kalivas P.W. Sensitization to cocaine and dopamine autoreceptor subsensitivity in the nucleus accumbens. Synapse 1995, 20:33-36.
69. Podet A., Lee M.J., Swann A.C., Dafny N. Nucleus accumbens lesions modulate the effects of methylphenidate. Brain Res. Bull. 2010, 82:293-301.
70. Prieto-Gomez B., Benitez M.T., Vazquez-Alvarez A.M., Yang P.B., Reyes Vazquez C., Dafny N. Dopaminergic ventral tegmental neurons modulated by methylphenidate. Life Sci. 2004, 74:1581-1592.
71. Prieto-Gomez B., Vazquez-Alvarez A.M., Martinez-Pena J.L., Reyes-Vazquez C., Yang P.B., Dafny N. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area. Life Sci. 2005, 77:635-649.
72. Reyes-Vazquez C., Prieto-Gomez B., Dafny N. Alpha-interferon suppresses food intake and neuronal activity of the lateral hypothalamus. Neuropharmacology 1994, 33:1545-1552.
73. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 1986, 396:157-198.
74. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 1993, 18:247-291.
75. Robinson T.E., Jurson P.A., Bennett J.A., Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 1988, 462:211-222.
76. Rowland A.S., Umbach D.M., Catoe K.E., Stallone L., Long S., Rabiner D., Naftel A.J., Panke D., Faulk R., Sandler D.P. Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results. Can. J. Psychiatry 2001, 46:931-940.
77. Ruskin D.N., Bergstrom D.A., Shenker A., Freeman L.E., Baek D., Walters J.R. Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action. Biol. Psychiatry 2001, 49:340-350.
78. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J. Comp. Neurol. 1989, 290:213-242.
79. Shi W.X., Zheng P., Liang X.F., Bunney B.S. Characterization of dopamine-induced depolarization of prefrontal cortical neurons. Synapse 1997, 26:415-422.
80. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav. Brain Res. 1998, 94:127-152.
81. Steketee J.D. Intra-A10 injection of H7 blocks the development of sensitization to cocaine. Neuroreport 1994, 6:69-72.
82. Steketee J.D., Kalivas P.W. Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. J. Pharmacol. Exp. Ther. 1991, 259:916-924.
83. Steketee J.D., Sorg B.A., Kalivas P.W. The role of the nucleus accumbens in sensitization to drugs of abuse. Prog. Neuropsychopharmacol. Biol. Psychiatry 1992, 16:237-246.
84. Stowe Z.N., Landry J.C., Tang Z., Owens M.J., Kinkead B., Nemeroff C.B. The electrophysiological effects of neurotensin on spontaneously active neurons in the nucleus accumbens: an in vivo study. Synapse 2005, 58:165-172.
85. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 1982, 9:321-353.
86. Teo S.K., Stirling D.I., Thomas S.D., Khetani V.D. Neurobehavioral effects of racemic threo-methylphenidate and its D and L enantiomers in rats. Pharmacol. Biochem. Behav. 2003, 74:747-754.
87. Turrigiano G.G., Nelson S.B. Homeostatic plasticity in the developing nervous system. Nat. Rev. Neurosci. 2004, 5:97-107.
88. Vezina P. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 1993, 605:332-337.
89. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., Dewey S., Ashby C., Liebermann J., Hitzemann R., et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry 1995, 52:456-463.
90. Volkow N.D., Wang G.J., Fowler J.S., Fischman M., Foltin R., Abumrad N.N., Gatley S.J., Logan J., Wong C., Gifford A., Ding Y.S., Hitzemann R., Pappas N. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci. 1999, 65:PL7-PL12.
91. Volkow N.D., Wang G., Fowler J.S., Logan J., Gerasimov M., Maynard L., Ding Y., Gatley S.J., Gifford A., Franceschi D. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J. Neurosci. 2001, 21:RC121.
92. Wanchoo S.J., Swann A.C., Dafny N. Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate. Brain Res. 2009, 1301:68-79.
93. Wanchoo S.J., Lee M.J., Swann A.C., Dafny N. Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate. Brain Res. 2010, 1312:89-100.
94. White F.J., Hu X.T., Henry D.J. Electrophysiological effects of cocaine in the rat nucleus accumbens: microiontophoretic studies. J. Pharmacol. Exp. Ther. 1993, 266:1075-1084.
95. Wilens T.E., Faraone S.V., Biederman J., Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003, 111:179-185.
96. Wise R.A., Bozarth M.A. Brain substrates for reinforcement and drug self-administration. Prog. Neuropsychopharmacol. 1981, 5:467-474.
97. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 1998, 54:679-720.
98. Wolf M.E., Xue C.J. Amphetamine and D1 dopamine receptor agonists produce biphasic effects on glutamate efflux in rat ventral tegmental area: modification by repeated amphetamine administration. J. Neurochem. 1998, 70:198-209.
99. Wolf M.E., Xue C.J., White F.J., Dahlin S.L. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Res. 1994, 666:223-231.
100. Wolf M.E., Sun X., Mangiavacchi S., Chao S.Z. Psychomotor stimulants and neuronal plasticity. Neuropharmacology 2004, 47(Suppl 1):61-79.
101. Yang P., Beasley A., Swann A., Dafny N. Valproate modulates the expression of methylphenidate (ritalin) sensitization. Brain Res. 2000, 874:216-220.
102. Yang P., Singhal N., Modi G., Swann A., Dafny N. Effects of lithium chloride on induction and expression of methylphenidate sensitization. Eur. J. Pharmacol. 2001, 426:65-72.
103. Yang P.B., Amini B., Swann A.C., Dafny N. Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Res. 2003, 971:139-152.
104. Yang P.B., Swann A.C., Dafny N. Chronic methylphenidate modulates locomotor activity and sensory evoked responses in the VTA and NAc of freely behaving rats. Neuropharmacology 2006, 51:546-556.
105. Yang P.B., Swann A.C., Dafny N. Dose-response characteristics of methylphenidate on locomotor behavior and on sensory evoked potentials recorded from the VTA, NAc, and PFC in freely behaving rats. Behav. Brain Funct. 2006, 2:3.
106. Yang P.B., Swann A.C., Dafny N. Sensory-evoked potentials recordings from the ventral tegmental area, nucleus accumbens, prefrontal cortex, and caudate nucleus and locomotor activity are modulated in dose-response characteristics by methylphenidate. Brain Res. 2006, 1073-1074:164-174.
107. Yang P.B., Swann A.C., Dafny N. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res. Bull. 2006, 71:301-310.
108. Yang P.B., Swann A.C., Dafny N. Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization. Brain Res. 2007, 1145:66-80.
109. Yang P.B., Swann A.C., Dafny N. Methylphenidate treated at the test cage - dose-dependent sensitization or tolerance depend on the behavioral assay used. Crit. Rev. Neurobiol. 2007, 19:59-77.
110. Yang P.B., Swann A.C., Dafny N. Psychostimulants given in adolescence modulate their effects in adulthood using the open field and the wheel-running assays. Brain Res. Bull. 2010, 82:208-217.
111. Yang P.B., Cuellar D.O., Swann A.C., Dafny N. Age and genetic strain differences in response to chronic methylphenidate administration. Behav. Brain Res. 2011, 218:206-217.